Skip to main content
VCbacked
Log inGet Started

ProVerum Medical

Dublin, Ireland

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

$80.0M raised
Aug 2025
Series B
Health CareMedical Device

Top Investors

OrbiMedLightstone VenturesEnterprise IrelandMVM Life Science PartnersIreland Strategic Investment Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ProVerum Medical

How much funding has ProVerum Medical raised?
ProVerum Medical has raised $80.0M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
Who are ProVerum Medical's investors?
ProVerum Medical's investors include OrbiMed, Lightstone Ventures, Enterprise Ireland, MVM Life Science Partners, Ireland Strategic Investment Fund.
Where is ProVerum Medical headquartered?
ProVerum Medical is headquartered in Dublin, Ireland.
What does ProVerum Medical do?
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
What stage is ProVerum Medical at?
ProVerum Medical is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ProVerum Medical — Funding & Investors." VCBacked, August 25, 2025, https://www.vcbacked.co/company/proverum-medical. Accessed June 3, 2026.
APA
VCBacked. (2025). ProVerum Medical — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/proverum-medical
Wikipedia (cite web)
{{cite web |title=ProVerum Medical — Funding & Investors |url=https://www.vcbacked.co/company/proverum-medical |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K